![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-desktop-header-newgif-91648.gif)
![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-header-mobile-newgif-14167.gif)
X
19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BIMATOPROST, with a corresponding application number 211911 and regulatory information .
proudly manufactured in the
approval since 2020-03-04
AbbVie Inc's DURYSTA IMPLANT;OPHTHALMIC, medication with 10MCG of BIMATOPROST.